This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / Optum Expands NeuroStar TMS Coverage
Regulatory policy update

Optum Expands NeuroStar TMS Coverage

Analysis based on 6 articles · First reported Apr 13, 2026 · Last updated Apr 13, 2026

Sentiment
60
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The policy update by UnitedHealth Group — Optum/United Healthcare/United Behavioral Health is expected to positively impact Neuronetics by increasing access to its NeuroStar Advanced Therapy, potentially leading to higher revenue and stock performance. This expansion of care by UnitedHealth Group's subsidiary could also improve mental healthcare access for millions of covered lives.

Healthcare Medical Technology
Event Summary

UnitedHealth Group — Optum/United Healthcare/United Behavioral Health (UnitedHealth Group — Optum/UHC/UBH) has updated its Transcranial Magnetic Stimulation (TMS) clinical policy to allow psychiatric mental health nurse practitioners (PMHNPs) to order, supervise, and administer TMS therapy. This change, previously limited to psychiatrists, expands access to NeuroStar Advanced Therapy, a non-drug depression treatment made by Neuronetics, across 26 states and Washington, D.C. The policy update affects 34.8 million UnitedHealth Group — Optum/UHC/UBH commercial covered lives and is seen as a significant milestone for mental healthcare, particularly in underserved communities. Neuronetics' dedicated health policy team played a key role in advocating for this change. Brian Banks, owner of Lighthouse Mental Wellness, praised the policy for recognizing PMHNPs' qualifications and opening access for more patients.

Entities Involved
stock
Neuronetics
Neuronetics, as the maker of NeuroStar Advanced Therapy, benefits from the expanded access to its treatment due to the policy update by UnitedHealth Group — Optum/United Healthcare/United Behavioral Health.
Importance 100.0 Sentiment 70.0
stock
UnitedHealth Group
UnitedHealth Group's subsidiary, UnitedHealth Group — Optum/United Healthcare/United Behavioral Health, updated its policy, which could lead to increased utilization of mental health services for its members.
Importance 90.0 Sentiment 50.0
subs
UnitedHealth Group — Optum
UnitedHealth Group — Optum, along with United Healthcare and United Behavioral Health, updated its clinical policy to allow psychiatric mental health nurse practitioners to administer TMS therapy, increasing access to care for its 34.8 million commercial covered lives.
Importance 90.0 Sentiment 50.0
stock
Greenbrook TMS
Greenbrook TMS, operated by Neuronetics, will likely see increased patient volume for NeuroStar Advanced Therapy due to the expanded policy.
Importance 50.0 Sentiment 70.0
per
Dan Reuvers
Dan Reuvers, President and CEO of Neuronetics, Inc., expressed pride in his company's health policy team for their role in achieving the policy update.
Importance 40.0 Sentiment 60.0
per
Brian Banks
Brian Banks, owner of Lighthouse Mental Wellness, applauded Neuronetics' advocacy efforts, highlighting the positive impact of the policy update on patient access to NeuroStar TMS therapy.
Importance 30.0 Sentiment 60.0
cnt
United States
Importance 0.0 Sentiment 0.0
Relationships
UnitedHealth Group related ↔ United States
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.